Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Search
Sign in
Sign up
Charles Schwab’s
ARS Pharmaceuticals
SPRY
Stock Holding History
Charles Schwab’s Portfolio
SPRY Stock Details
SPRY Fund Activity
Bought
Maintained
Sold
Shares
Quarter
Market Value
Status
Shares
Change in
Stake
Trade Value
Portfolio Weight
Portfolio Position
2026
Q1
$4.28M
Sell
533,394
-17,538
-3%
-$168K
﹤0.01%
2468
2025
Q4
$6.42M
Buy
550,932
+30,174
+6%
+$293K
﹤0.01%
2336
2025
Q3
$5.23M
Buy
520,758
+78,556
+18%
+$1.13M
﹤0.01%
2422
2025
Q2
$7.72M
Buy
442,202
+25,545
+6%
+$369K
﹤0.01%
2138
2025
Q1
$5.24M
Sell
416,657
-10,820
-3%
-$130K
﹤0.01%
2254
2024
Q4
$4.51M
Buy
427,477
+3,530
+0.8%
+$49.4K
﹤0.01%
2373
2024
Q3
$6.15M
Buy
423,947
+8,417
+2%
+$100K
﹤0.01%
2269
2024
Q2
$3.54M
Buy
415,530
+70,235
+20%
+$623K
﹤0.01%
2511
2024
Q1
$3.53M
Buy
345,295
+15,745
+5%
+$117K
﹤0.01%
2416
2023
Q4
$1.81M
Buy
329,550
+5,147
+2%
+$22.6K
﹤0.01%
2651
2023
Q3
$1.23M
Buy
324,403
+252,792
+353%
+$1.66M
﹤0.01%
2736
2023
Q2
$480K
Buy
71,611
+55,441
+343%
+$370K
﹤0.01%
3075
2023
Q1
$105K
Hold
16,170
–
–
﹤0.01%
3242
2022
Q4
$138K
Buy
+16,170
New
+$105K
﹤0.01%
3230
2022
Q3
–
Sell
-106,414
Closed
-$452K
–
3547
2022
Q2
$452K
Sell
106,414
-40,961
-28%
-$143K
﹤0.01%
3110
2022
Q1
$518K
Sell
147,375
-1,568
-1%
-$6.83K
﹤0.01%
3092
2021
Q4
$992K
Buy
148,943
+9,838
+7%
+$79.9K
﹤0.01%
2914
2021
Q3
$1.39M
Buy
139,105
+53,301
+62%
+$1.31M
﹤0.01%
2774
2021
Q2
$2.65M
Buy
85,804
+1,391
+2%
+$44.6K
﹤0.01%
2618
2021
Q1
$3.68M
Buy
+84,413
New
+$3.99M
﹤0.01%
2442
Other funds holding SPRY
RCM
RA Capital Management
Boston, Massachusetts
$9.44B AUM
157.3%
1-Year Est. Return
O
OrbiMed
New York
$5.05B AUM
125.28%
1-Year Est. Return
RCMNY
Rubric Capital Management (New York)
New York
$9.44B AUM
68.42%
1-Year Est. Return
DM
Deerfield Management
New York
$8.48B AUM
99.04%
1-Year Est. Return
Millennium Management
New York
$240B AUM
35.51%
1-Year Est. Return
BlackRock
New York
$5.72T AUM
30.48%
1-Year Est. Return
Aberdeen Group
Edinburgh, United Kingdom
$61.9B AUM
29.81%
1-Year Est. Return
SOCM
SR One Capital Management
Wayne, Pennsylvania
$915M AUM
209.71%
1-Year Est. Return
State Street
Boston, Massachusetts
$2.9T AUM
29.55%
1-Year Est. Return
Franklin Resources
San Mateo, California
$408B AUM
30.18%
1-Year Est. Return
Sign up
Sign in
Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Theme
Close